An experimental study in pancreatic cancer showed that CXCL12 interrupts the growth and metastasis of primary tumor through cell-cycle arrest, ultimately leading to an increase in overall survival (Roy et al. 2014). This evidence concerns the gene CXCL12 and neoplasm.